GEN News Highlights

Jul 11 2006, 3:49 PM EST

Lion Biosciences to Take Over Axaron Bioscience through Acquisition of Sygnis

GEN News Highlights

LION bioscience signed a contract acquiring Sygnis Bioscience. After that deal goes through, Axaron bioscience will assign its entire operating business to Sygnis Bioscience. Axaron Bioscience, founded in 1997, develops therapies to treat neurodegenerative diseases. AX200, a product for the treatment of strokes, is the company’s most advanced compound and is currently being tested in a Phase IIa clinical trial. Lion has been restructuring its operations since the end of 2004.

Comment on this News:

CAREER CENTER

visit the Career Center

WEBINARS

GEN Webinars: Novel Approaches for Lipid Profiling and Analysis
Date: Wednesday, February 17, 2010
This webinar will highlight the importance of chromatography in lipidomic studies, the advantages of ...learn more.

view all webinars

GEN and Scintellix bring you the Cryptogram Challenge: RNAi!

PODCASTS

INTERVIEW: NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates ...MORE

MOST POPULAR

News

Most Viewed	Most Emailed	Top Searches
Gene Variant that Optimizes Thinking but Increases Risk of Schizophrenia Identified by NIM...
Roche Allies with MGH and Harvard to Develop Stem Cell-Derived Cell Lines for Drug Discove...
Life Technologies Gains on Race toward $1,000 Genome
U87MG Glioblastoma Cell Line Sequenced in Under a Month
Case against the Patentability of Genes Begins Today
Merck & Co. Taps Envoy for Target Discovery in Diabetes and Obesity

Most Viewed	Most Emailed	Top Searches
Assay that Examines Hundreds of Proteins Simultaneously Invented
Scientists Solve 3-D Crystal Structure of Retroviral Integrase Bound to Viral DNA
Roche Allies with MGH and Harvard to Develop Stem Cell-Derived Cell Lines for Drug Discove...
Life Technologies Gains on Race toward $1,000 Genome
Case against the Patentability of Genes Begins Today
U87MG Glioblastoma Cell Line Sequenced in Under a Month

Most Viewed	Most Emailed	Top Searches
Scientists Solve 3-D Crystal Structure of Retroviral Integrase Bound to Viral DNA
Roche Allies with MGH and Harvard to Develop Stem Cell-Derived Cell Lines for Drug Discove...
U87MG Glioblastoma Cell Line Sequenced in Under a Month
EC Sanctions Roche’s Herceptin for HER2-Positive Metastatic Gastric Cancer
Scientists Identify Pathway that Helps Pancreatic Cancer Surpass Chemotherapy
Investigators Identify Gene with Prognostic Value for Breast Cancer

Articles

Most Viewed	Most Emailed	Top Searches
Dissecting Cancer Stem Cell Theories
Insights Accrue on Epigenetic Modification
Epigenetic Research Surges on Many Fronts
Court Ruling Could Lengthen Patent Term
Epigenetics Offers Strategies for New Drugs
Healing the Achilles Heel of Proteomics

Most Viewed	Most Emailed	Top Searches
Epigenetic Research Surges on Many Fronts
Court Ruling Could Lengthen Patent Term
Microbioreactors Carve Out Growing Niche
Finding the Right Outsourcing Balance
Insights Accrue on Epigenetic Modification
Epigenetics Offers Strategies for New Drugs

Most Viewed	Most Emailed	Top Searches
EcoBiotics Scours Rainforest for Compounds
Optimizing CHO Cell Culture Conditions
Funding Embryonic Stem Cell Research
Epigenetic Research Surges on Many Fronts
Dissecting Cancer Stem Cell Theories
Epigenetics Offers Strategies for New Drugs

Blogs

Most Viewed	Most Emailed	Top Searches
LabAuto 2010
Academics who Work in Industry - At What Cost?
It’s the process, stupid. Biofuels from microalgae are not yet sustainable.
Mammography Guidelines - Bring on the Controversy!
Genetically Modified Foods Debate
New Prognostic Genetic Test for Adolescent Scoliosis

Most Viewed	Most Emailed	Top Searches
Biosimilar Approval in the U.S. and Europe: How Similar Are They?
It’s the process, stupid. Biofuels from microalgae are not yet sustainable.
Academics who Work in Industry - At What Cost?

Most Viewed	Most Emailed	Top Searches
Genetically Modified Foods Debate
LabAuto 2010
It’s the process, stupid. Biofuels from microalgae are not yet sustainable.
Biosimilar Approval in the U.S. and Europe: How Similar Are They?
Drug Target Identification and Validation
Dr. James Watson Controversy

Name:
Title:
Comment:
	HELP US FIGHT SPAMMING ROBOTS by answering the following simple question. It will verify you as a legitimate user wishing to post a comment. Thank you for your cooperation.

CURRENT ISSUE

SUBSCRIBE

AD LINK

GEN News Highlights